PDT Partners’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-20,664
| Closed | -$431K | – | 764 |
|
|
2024
Q4 | $431K | Buy |
20,664
+1,030
| +5% | +$21.5K | 0.04% | 511 |
|
|
2024
Q3 | $390K | Buy |
+19,634
| New | +$390K | 0.03% | 559 |
|
|
2022
Q4 | – | Sell |
-46,943
| Closed | -$602K | – | 681 |
|
|
2022
Q3 | $602K | Buy |
46,943
+7,748
| +20% | +$99.4K | 0.09% | 381 |
|
|
2022
Q2 | $275K | Buy |
39,195
+478
| +1% | +$3.35K | 0.02% | 756 |
|
|
2022
Q1 | $321K | Buy |
+38,717
| New | +$321K | 0.03% | 705 |
|
|
2020
Q3 | – | Sell |
-276,900
| Closed | -$1.28M | – | 738 |
|
|
2020
Q2 | $1.28M | Sell |
276,900
-50,100
| -15% | -$231K | 0.09% | 246 |
|
|
2020
Q1 | $1.26M | Sell |
327,000
-68,782
| -17% | -$265K | 0.1% | 203 |
|
|
2019
Q4 | $1.48M | Buy |
395,782
+210,977
| +114% | +$791K | 0.09% | 223 |
|
|
2019
Q3 | $981K | Buy |
+184,805
| New | +$981K | 0.06% | 283 |
|